Biomind Labs is a biotech research and development company aimed at transforming biomedical sciences knowledge into novel psychotropic drugs and innovative nanotech delivery systems for a variety of psychiatric and neurological conditions. Through its acceleration platform, Biomind Labs is developing novel pharmaceutical formulations of the main psychedelic molecules, N, N‑dimethyltryptamine (DMT), 5‑MeO‑DMT and mescaline for treating a wide range of therapeutic indications. Biomind Labs’ focus is to guarantee patients access to affordable and modern‑day treatments and use cases.
Biomind Labs
